Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
European Urology|August 16, 2017
Cost Effectiveness of Nivolumab in Advanced Renal Cell CarcinomaMichal Sarfaty, Moshe Leshno, Noa Gordon, et al.
Population Health Management|January 19, 2017
Exploring Variation in Transformation of Primary Care Practices to Patient-Centered Medical Homes: A Mixed Methods ApproachRobert D Lieberthal, Tom Karagiannis, Evan Bilheimer, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|July 13, 2001
A follow-up study of the characteristics of dean's lettersD D Hunt, C MacLaren, C Scott, et al.
Cancers|February 25, 2022
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell CarcinomaShira Sagie, Moran Gadot, Meital Levartovsky, et al.
The Oncologist|February 3, 2019
A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell CarcinomaDaniel Reinhorn, Michal Sarfaty, Moshe Leshno, et al.
Human Gene Therapy|September 10, 2005
Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirionsChava Kimchi-Sarfaty, Scott Brittain, Susan Garfield, et al.
Cancers|July 9, 2022
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy EraShira Sagie, Michal Sarfaty, Meital Levartovsky, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 14, 2012
Plasma derivatives: new products and new approachesZuben E Sauna, Gouri Shankar Pandey, Nisha Jain, et al.
Biochemistry|April 18, 1995
An L40C mutation converts the cysteine-sulfenic acid redox center in enterococcal NADH peroxidase to a disulfideH Miller, S S Mande, D Parsonage, et al.
Medical Education Online|September 19, 2019
Development of an empathy and clarity rating scale to measure the effect of medical improv on end-of-first-year OCSE performance: a pilot studyCarol A Terregino, H Liesel Copeland, Suzanne C Sarfaty, et al.
Pageof 25